Modulation of glucagon-like peptide 1 and energy metabolism by inulin and oligofructose: experimental data - PubMed

Affiliations

• PMID: 17951500
• DOI: 10.1093/jn/137.11.2547S

Free article

Review

Modulation of glucagon-like peptide 1 and energy metabolism by inulin and oligofructose: experimental data

Nathalie M Delzenne et al. J Nutr. 2007 Nov.

Free article

Abstract

Inulin-type fructans have been tested for their capacity to modulate lipid and glucose metabolism in several animal models. Oligofructose (OFS) decreases food intake, fat mass development, and hepatic steatosis in normal and in obese rats; moreover, it exerts an antidiabetic effect in streptozotocin-treated rats and high-fat-fed mice. In most cases, the beneficial effects of OFS are linked to an increase of glucagon-like peptide-1 (GLP-1) level in the portal vein and of GLP-1 and proglucagon mRNA, its precursor, in the proximal colon. In this organ, OFS increases the number of GLP-1-positive L cells by promoting factors (Neurogenin 3 and NeuroD) involved in the differentiation of stem cells into L cells. The chronic administration of GLP-1 receptor antagonist exendin 9-39 totally prevents the beneficial effects of OFS (improved glucose tolerance, fasting blood glucose, glucose-stimulated insulin secretion, insulin-sensitive hepatic glucose production, and reduced body weight gain). Furthermore GLP-1 receptor knockout mice are completely insensitive to the antidiabetic actions of OFS. These findings highlight the potential interest of enhancing endogenous GLP-1 secretion by inulin-type fructans for the prevention/treatment of obesity and type 2 diabetes. Moreover, OFS is also able to modulate other gastrointestinal peptides (such as PYY and ghrelin) that could be involved in the control of food intake. Several studies in humans already support interest in OFS in the control of satiety, triglyceridemia, or steatohepatitis. The link with gut peptides production in humans remains to be proven.

Similar articles

• Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor.

  Cani PD, Knauf C, Iglesias MA, Drucker DJ, Delzenne NM, Burcelin R. Cani PD, et al. Diabetes. 2006 May;55(5):1484-90. doi: 10.2337/db05-1360. Diabetes. 2006. PMID: 16644709

• Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1.

  Cani PD, Neyrinck AM, Maton N, Delzenne NM. Cani PD, et al. Obes Res. 2005 Jun;13(6):1000-7. doi: 10.1038/oby.2005.117. Obes Res. 2005. PMID: 15976142

• Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats.

  Cani PD, Dewever C, Delzenne NM. Cani PD, et al. Br J Nutr. 2004 Sep;92(3):521-6. doi: 10.1079/bjn20041225. Br J Nutr. 2004. PMID: 15469657

• Inulin and oligofructose modulate lipid metabolism in animals: review of biochemical events and future prospects.

  Delzenne NM, Daubioul C, Neyrinck A, Lasa M, Taper HS. Delzenne NM, et al. Br J Nutr. 2002 May;87 Suppl 2:S255-9. doi: 10.1079/BJNBJN/2002545. Br J Nutr. 2002. PMID: 12088526 Review.

Cited by

• Transmissible microbial and metabolomic remodeling by soluble dietary fiber improves metabolic homeostasis.

  He B, Nohara K, Ajami NJ, Michalek RD, Tian X, Wong M, Losee-Olson SH, Petrosino JF, Yoo SH, Shimomura K, Chen Z. He B, et al. Sci Rep. 2015 Jun 4;5:10604. doi: 10.1038/srep10604. Sci Rep. 2015. PMID: 26040234 Free PMC article.

• High fat diet induces microbiota-dependent silencing of enteroendocrine cells.

  Ye L, Mueller O, Bagwell J, Bagnat M, Liddle RA, Rawls JF. Ye L, et al. Elife. 2019 Dec 3;8:e48479. doi: 10.7554/eLife.48479. Elife. 2019. PMID: 31793875 Free PMC article.

• Influence of intestinal microbiota on body weight gain: a narrative review of the literature.

  Cardinelli CS, Sala PC, Alves CC, Torrinhas RS, Waitzberg DL. Cardinelli CS, et al. Obes Surg. 2015 Feb;25(2):346-53. doi: 10.1007/s11695-014-1525-2. Obes Surg. 2015. PMID: 25511750 Review.

• Recent Innovations in Non-dairy Prebiotics and Probiotics: Physiological Potential, Applications, and Characterization.

  Khan FF, Sohail A, Ghazanfar S, Ahmad A, Riaz A, Abbasi KS, Ibrahim MS, Uzair M, Arshad M. Khan FF, et al. Probiotics Antimicrob Proteins. 2023 Apr;15(2):239-263. doi: 10.1007/s12602-022-09983-9. Epub 2022 Sep 5. Probiotics Antimicrob Proteins. 2023. PMID: 36063353 Review.

• Fructooligosaccharides exert intestinal anti-inflammatory activity in the CD4+ CD62L+ T cell transfer model of colitis in C57BL/6J mice.

  Capitán-Cañadas F, Ocón B, Aranda CJ, Anzola A, Suárez MD, Zarzuelo A, de Medina FS, Martínez-Augustin O. Capitán-Cañadas F, et al. Eur J Nutr. 2016 Jun;55(4):1445-54. doi: 10.1007/s00394-015-0962-6. Epub 2015 Jul 8. Eur J Nutr. 2016. PMID: 26154776

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information